SCHEMBL6128802

SCHEMBL6128802

CNc1nccc(-c2cc(NC(=O)CNc3ncccn3)c3cc(OC)ccc3c2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.43
NCOR1 O75376 1/20 0.43
HDAC2 Q92769 1/20 0.43
PIK3CA P42336 2/20 0.39
PIK3CG P48736 2/20 0.39
PIK3CB P42338 1/20 0.39
DYRK1A Q13627 4/20 0.39
CLK4 Q9HAZ1 4/20 0.39
DYRK1B Q9Y463 3/20 0.39
HPGD P15428 3/20 0.38
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
RGS12 O14924 1/20 0.38
HTT P42858 1/20 0.38
CLK1 P49759 3/20 0.38
CLK2 P49760 2/20 0.37
HDAC1 Q13547 1/20 0.37
AURKB Q96GD4 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2679375 0.93 HDAC3 (0.41) HDAC3NCOR1HDAC2PIK3CAPIK3CG
SCHEMBL6128580 0.90 HDAC3 (0.40) HDAC3NCOR1HDAC2PIK3CAPIK3CG
SCHEMBL6128566 0.89 HDAC3 (0.46) HDAC3NCOR1HDAC2PIK3CAPIK3CG
SCHEMBL2178808 0.89 CASP2 (0.41) HDAC3NCOR1HDAC2PIK3CAPIK3CG
SCHEMBL6128772 0.89 NPC1 (0.44) HDAC3NCOR1HDAC2PIK3CAPIK3CG
SCHEMBL6128567 0.88 HDAC3 (0.38) HDAC3NCOR1HDAC2PIK3CAPIK3CG
SCHEMBL2175597 0.87 HDAC3 (0.39) HDAC3NCOR1HDAC2PIK3CAPIK3CG
SCHEMBL2678820 0.86 MEN1 (0.42) HDAC3NCOR1HDAC2PIK3CAPIK3CG
SCHEMBL6128782 0.86 HDAC3 (0.38) HDAC3NCOR1HDAC2PIK3CAPIK3CG
SCHEMBL6128762 0.86 NPC1 (0.43) HDAC3NCOR1HDAC2HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP HDAC3 1641/4885NCOR1 418/4885HDAC2 2152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.